SHC3: A Drug Target / Disease Biomarker (G53358)

Target Name: SHC3

NCBI ID: G53358

SHC3

SHC3: A Drug Target / Disease Biomarker

SHC3, short for solute carrier family 3 member 3, is a protein that is expressed in various tissues throughout the body. It plays a critical role in the transport of a variety of molecules, including nutrients, waste products, and medications. SHC3 is also involved in cellular signaling and has been linked to a number of diseases, including cancer.

Recent research has focused on the potential of SHC3 as a drug target or biomarker. Studies have shown that SHC3 can be targeted by small molecules, such as inhibitors, and that these inhibitors can lead to significant improvements in the treatment of certain diseases. Additionally, SHC3 has been shown to be involved in a number of diseases, including cancer, and its levels have been found to be altered in a variety of cancer types.

One of the key advantages of SHC3 as a drug target is its widespread expression in various tissues. This makes it a promising candidate for targeting a variety of diseases, as it is likely to be expressed in many different types of cells and tissues. Additionally, SHC3's involvement in a number of different cellular processes makes it a potentially versatile target.

Another advantage of SHC3 is its ability to interact with a variety of different molecules. Studies have shown that SHC3 can interact with a wide range of molecules, including transcription factors, proteins involved in signaling pathways, and intracellular signaling molecules. This makes it a potentially attractive target for drugs that target these molecules.

In addition to its potential as a drug target, SHC3 has also been shown to be a potential biomarker. Studies have shown that SHC3 is expressed in a variety of tissues and that its levels can be used as a marker for certain types of cancer. Additionally, SHC3 has been shown to be involved in the development and progression of certain diseases, making it a potentially useful biomarker for these conditions.

Overall, SHC3 is a protein that has the potential to be a drug target or biomarker. Its widespread expression in various tissues and its ability to interact with a variety of different molecules make it a promising candidate for both of these roles. Further research is needed to fully understand the potential of SHC3 as a drug target or biomarker.

Protein Name: SHC Adaptor Protein 3

Functions: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons

The "SHC3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHC3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets